Stephen Aherne

Stephen Aherne

Pharma Partner, PwC United Kingdom

Stephen is a Partner within the PwC Valuation and Strategy practice and leads the Pharmaceutical and Healthcare valuation offering.

He has over 14 years of experience within PwC, including 13 years specialising in the pharmaceutical and healthcare sectors.

Stephen has provided industry specific valuation advice for mergers and acquisitions, financial reporting, expert opinions, corporate restructuring and refinancing purposes. He regularly conducts both business valuations and intellectual property valuations such as licences, patents and trademarks. He has also led strategy projects and market analysis for pharmaceutical and healthcare clients.

His clients include large and medium pharmaceutical, medical technology, biotechnology and both public and private healthcare companies.

He presents externally on valuations in the pharmaceutical sector, for example at the Association of British Pharmaceutical Industry Intellectual Property Seminar on “Valuing your IP Assets”.

Specialism

  • Pharmaceutical and healthcare